181 related articles for article (PubMed ID: 32103875)
1. Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence.
Luo YG; Duan LW; Ji X; Jia WY; Liu Y; Sun ML; Liu GM
World J Gastroenterol; 2020 Feb; 26(6):670-685. PubMed ID: 32103875
[TBL] [Abstract][Full Text] [Related]
2. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
3. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
5. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
6. Expression and Regulatory Network Analysis of MiR-139-3p, a New Potential Serum Biomarker for Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Wang Y; Fang Q; Tian L; Yuan Z; Tian L; Zhou Z
Technol Cancer Res Treat; 2020; 19():1533033820920967. PubMed ID: 32356485
[TBL] [Abstract][Full Text] [Related]
7. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
11. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.
Maghsudlu M; Farashahi Yazd E; Amiriani T
J Gastrointest Cancer; 2020 Mar; 51(1):227-233. PubMed ID: 31020570
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
16. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
Luo HS; Wu DH
Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
18. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
19. NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma.
Wu X; Lim ZF; Li Z; Gu L; Ma W; Zhou Q; Su H; Wang X; Yang X; Zhang Z
Oncol Res Treat; 2017; 40(6):370-374. PubMed ID: 28482344
[TBL] [Abstract][Full Text] [Related]
20. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
